BRIEF-Humacyte Q3 Operating Expenses USD 30.233 Million

Reuters
08 Nov 2024
BRIEF-Humacyte Q3 Operating Expenses USD 30.233 Million

Nov 08 (Reuters) - Humacyte Q3 operating income USD -30.233 million vs. IBES estimate USD -29.7 million.

  • Q3 net income USD -39.202 million vs. IBES estimate USD -30 million
  • Q3 basic EPS USD -0.33

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10